Drug class in one race
TYK2 drugs for Psoriasis
11 tracked TYK2 drugs in the Psoriasis race. The class explanation lives on the TYK2 page; the full indication pipeline across every mechanism is on the Psoriasis page.
1 approved / phase 47 Phase 31 Phase 2/31 Phase 21 Phase 1/2
Head-to-head evidence: BMS-986322 vs CMS-D001 · BMS-986322 vs CS32582 · BMS-986322 vs Envudeucitinib · BMS-986322 vs HS-10374 · BMS-986322 vs ICP-488 · BMS-986322 vs SYHX1901